Vaccines

22 Mar 2007 Acambis PLC (ACAM) is First Company to Test a West Nile Virus Vaccine in Older Adults
21 Mar 2007 GenVec Signs Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop RSV Vaccines
16 Mar 2007 British doctors to start new phase III trial with Pharmexa's GV1001
15 Mar 2007 Novel tuberculosis vaccine shows promising immunogenicity and safety profile
15 Mar 2007 Prima Biomed Final Phase IIa Results for Ovarian Cancer Treatment Exceeded Expectations
15 Mar 2007 immatics granted orphan drug status for therapeutic cancer vaccine IMA901
14 Mar 2007 Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
13 Mar 2007 Preclinical Update – Debio-0512 Therapeutic Vaccine For The Treatment Of Chronic And Acute Inflammatory Conditions
10 Mar 2007 Curalogic has started clinical EU phase III trial with its ragweed product
09 Mar 2007 Diamyd Medical Announces Phase III Clinical Trials Plan For Diamyd(R) In Type 1 Diabetes
06 Mar 2007 New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1
06 Mar 2007 Iomai Vaccine for Travelers' Diarrhea Blunts Severity of Disease in Clinical Study
06 Mar 2007 Nventa Announces Presentation Of Positive HSPE7 Data From Nci-Sponsored Clinical Trial In Cervical Dysplasia
02 Mar 2007 European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
02 Mar 2007 Dynavax Initiates Phase I Trial of Hepatitis B Therapy
02 Mar 2007 Genelabs Announces Publication In New England Journal Of Medicine Of Clinical Trial Results With Hepatitis E Virus Vaccine
02 Mar 2007 Acambis’ JE vaccine meets and exceeds primary endpoint in pivotal Phase 3 efficacy trial
01 Mar 2007 Phase I Data From Targeted Genetics' tgAAC09 Vaccine for HIV/AIDS Presented at Scientific Conference
27 Feb 2007 Merck KGaA: Stimuvax Cancer Vaccine Phase III Study Begins
24 Feb 2007 Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval
24 Feb 2007 Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
23 Feb 2007 Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
22 Feb 2007 Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine'
20 Feb 2007 New Data Support Alphavax's Vaccine For CMV
16 Feb 2007 The Immune Response Corporation's Interim Phase II Data Suggest Both REMUNE and IR103 Stabilize CD4+ Cell Counts in Drug-Naive HIV Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top